{"entity":{"type":"insider","cik":"0001413823","url":"/insider/0001413823","json_url":"/insider/0001413823.json","name":"CHAI CHRISTOPHER Y","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":18,"n_filings":11,"first":"2009-02-11","last":"2020-08-20","span_basis":"filed_date"},"name_variants":[{"name":"CHAI CHRISTOPHER Y","source":"filing","n_filings":11,"first_seen":"2009-02-11","last_seen":"2020-08-20"}],"transactions":[{"id":2141970,"accession":"0001209191-20-047832","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-047832","line_url":"/filing/0001209191-20-047832#line-2","is_derivative":false,"issuer_cik":"0001413823","issuer_name":"Principia Biopharma Inc.","issuer_ticker":"PRNB","issuer_name_source":null,"issuer_url":"/issuer/0001413823","owner_cik":"0001413823","owner_name":"CHAI CHRISTOPHER Y","owner_display_name":"CHAI CHRISTOPHER Y","owner_url":"/insider/0001413823","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":99.3653,"price_display":"99.37","price_state":"stated","total_value":745239.75,"total_display":"745,239.75","total_whole":"745,240","shares_owned_after":3539.0,"shares_owned_after_display":"3,539","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-18","filed_date":"2020-08-20","scope":"insider"},{"id":3089519,"accession":"0001209191-20-031531","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-031531","line_url":"/filing/0001209191-20-031531#line-2","is_derivative":false,"issuer_cik":"0001413823","issuer_name":"Principia Biopharma Inc.","issuer_ticker":"PRNB","issuer_name_source":null,"issuer_url":"/issuer/0001413823","owner_cik":"0001413823","owner_name":"CHAI CHRISTOPHER Y","owner_display_name":"CHAI CHRISTOPHER Y","owner_url":"/insider/0001413823","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":65.1024,"price_display":"65.10","price_state":"stated","total_value":488268.0,"total_display":"488,268.00","total_whole":"488,268","shares_owned_after":3539.0,"shares_owned_after_display":"3,539","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-19","filed_date":"2020-05-21","scope":"insider"},{"id":3147886,"accession":"0001209191-20-011163","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-20-011163","line_url":"/filing/0001209191-20-011163","is_derivative":false,"issuer_cik":"0001413823","issuer_name":"Principia Biopharma Inc.","issuer_ticker":"PRNB","issuer_name_source":null,"issuer_url":"/issuer/0001413823","owner_cik":"0001413823","owner_name":"CHAI CHRISTOPHER Y","owner_display_name":"CHAI CHRISTOPHER Y","owner_url":"/insider/0001413823","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":65.8914766,"price_display":"65.89","price_state":"stated","total_value":494186.0745,"total_display":"494,186.07","total_whole":"494,186","shares_owned_after":9582.0,"shares_owned_after_display":"9,582","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-18","filed_date":"2020-02-20","scope":"insider","n_lines":6},{"id":9054110,"accession":"0001181431-11-050248","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-11-050248","line_url":"/filing/0001181431-11-050248#line-2","is_derivative":false,"issuer_cik":"0001401923","issuer_name":"MAP Pharmaceuticals, Inc.","issuer_ticker":"MAPP","issuer_name_source":null,"issuer_url":"/issuer/0001401923","owner_cik":"0001413823","owner_name":"CHAI CHRISTOPHER Y","owner_display_name":"CHAI CHRISTOPHER Y","owner_url":"/insider/0001413823","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32000.0,"shares_display":"32,000","price_per_share":15.3837,"price_display":"15.38","price_state":"stated","total_value":492278.4,"total_display":"492,278.40","total_whole":"492,278","shares_owned_after":7703.0,"shares_owned_after_display":"7,703","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-09-20","filed_date":"2011-09-22","scope":"insider"},{"id":7466182,"accession":"0001181431-10-047597","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-10-047597","line_url":"/filing/0001181431-10-047597#line-2","is_derivative":false,"issuer_cik":"0001401923","issuer_name":"MAP Pharmaceuticals, Inc.","issuer_ticker":"MAPP","issuer_name_source":null,"issuer_url":"/issuer/0001401923","owner_cik":"0001413823","owner_name":"CHAI CHRISTOPHER Y","owner_display_name":"CHAI CHRISTOPHER Y","owner_url":"/insider/0001413823","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16000.0,"shares_display":"16,000","price_per_share":14.0505,"price_display":"14.05","price_state":"stated","total_value":224808.0,"total_display":"224,808.00","total_whole":"224,808","shares_owned_after":6709.0,"shares_owned_after_display":"6,709","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-09-20","filed_date":"2010-09-22","scope":"insider"},{"id":7446848,"accession":"0001181431-10-038302","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-10-038302","line_url":"/filing/0001181431-10-038302#line-4","is_derivative":false,"issuer_cik":"0001401923","issuer_name":"MAP Pharmaceuticals, Inc.","issuer_ticker":"MAPP","issuer_name_source":null,"issuer_url":"/issuer/0001401923","owner_cik":"0001413823","owner_name":"CHAI CHRISTOPHER Y","owner_display_name":"CHAI CHRISTOPHER Y","owner_url":"/insider/0001413823","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":104000.0,"total_display":"104,000.00","total_whole":"104,000","shares_owned_after":6709.0,"shares_owned_after_display":"6,709","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-07-21","filed_date":"2010-07-22","scope":"insider"},{"id":7446845,"accession":"0001181431-10-038302","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-10-038302","line_url":"/filing/0001181431-10-038302#line-2","is_derivative":false,"issuer_cik":"0001401923","issuer_name":"MAP Pharmaceuticals, Inc.","issuer_ticker":"MAPP","issuer_name_source":null,"issuer_url":"/issuer/0001401923","owner_cik":"0001413823","owner_name":"CHAI CHRISTOPHER Y","owner_display_name":"CHAI CHRISTOPHER Y","owner_url":"/insider/0001413823","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":12.423,"price_display":"12.42","price_state":"stated","total_value":99384.0,"total_display":"99,384.00","total_whole":"99,384","shares_owned_after":6709.0,"shares_owned_after_display":"6,709","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-07-20","filed_date":"2010-07-22","scope":"insider"},{"id":7487694,"accession":"0001181431-10-028714","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-10-028714","line_url":"/filing/0001181431-10-028714#line-2","is_derivative":false,"issuer_cik":"0001401923","issuer_name":"MAP Pharmaceuticals, Inc.","issuer_ticker":"MAPP","issuer_name_source":null,"issuer_url":"/issuer/0001401923","owner_cik":"0001413823","owner_name":"CHAI CHRISTOPHER Y","owner_display_name":"CHAI CHRISTOPHER Y","owner_url":"/insider/0001413823","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16000.0,"shares_display":"16,000","price_per_share":14.7716,"price_display":"14.77","price_state":"stated","total_value":236345.6,"total_display":"236,345.60","total_whole":"236,346","shares_owned_after":6709.0,"shares_owned_after_display":"6,709","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-05-20","filed_date":"2010-05-21","scope":"insider"},{"id":7506764,"accession":"0001181431-10-018229","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-10-018229","line_url":"/filing/0001181431-10-018229#line-4","is_derivative":false,"issuer_cik":"0001401923","issuer_name":"MAP Pharmaceuticals, Inc.","issuer_ticker":"MAPP","issuer_name_source":null,"issuer_url":"/issuer/0001401923","owner_cik":"0001413823","owner_name":"CHAI CHRISTOPHER Y","owner_display_name":"CHAI CHRISTOPHER Y","owner_url":"/insider/0001413823","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":16.4682,"price_display":"16.47","price_state":"stated","total_value":131745.6,"total_display":"131,745.60","total_whole":"131,746","shares_owned_after":6709.0,"shares_owned_after_display":"6,709","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-03-24","filed_date":"2010-03-25","scope":"insider"},{"id":7506760,"accession":"0001181431-10-018229","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-10-018229","line_url":"/filing/0001181431-10-018229#line-2","is_derivative":false,"issuer_cik":"0001401923","issuer_name":"MAP Pharmaceuticals, Inc.","issuer_ticker":"MAPP","issuer_name_source":null,"issuer_url":"/issuer/0001401923","owner_cik":"0001413823","owner_name":"CHAI CHRISTOPHER Y","owner_display_name":"CHAI CHRISTOPHER Y","owner_url":"/insider/0001413823","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":16.7237,"price_display":"16.72","price_state":"stated","total_value":133789.6,"total_display":"133,789.60","total_whole":"133,790","shares_owned_after":6709.0,"shares_owned_after_display":"6,709","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-03-23","filed_date":"2010-03-25","scope":"insider"},{"id":5644164,"accession":"0001181431-09-049903","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-09-049903","line_url":"/filing/0001181431-09-049903#line-2","is_derivative":false,"issuer_cik":"0001401923","issuer_name":"MAP Pharmaceuticals, Inc.","issuer_ticker":"MAPP","issuer_name_source":null,"issuer_url":"/issuer/0001401923","owner_cik":"0001413823","owner_name":"CHAI CHRISTOPHER Y","owner_display_name":"CHAI CHRISTOPHER Y","owner_url":"/insider/0001413823","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":8.0722,"price_display":"8.07","price_state":"stated","total_value":80722.0,"total_display":"80,722.00","total_whole":"80,722","shares_owned_after":4979.0,"shares_owned_after_display":"4,979","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-11-02","filed_date":"2009-11-04","scope":"insider"},{"id":5735046,"accession":"0001181431-09-046825","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-09-046825","line_url":"/filing/0001181431-09-046825#line-2","is_derivative":false,"issuer_cik":"0001401923","issuer_name":"MAP Pharmaceuticals, Inc.","issuer_ticker":"MAPP","issuer_name_source":null,"issuer_url":"/issuer/0001401923","owner_cik":"0001413823","owner_name":"CHAI CHRISTOPHER Y","owner_display_name":"CHAI CHRISTOPHER Y","owner_url":"/insider/0001413823","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":10.2624,"price_display":"10.26","price_state":"stated","total_value":102624.0,"total_display":"102,624.00","total_whole":"102,624","shares_owned_after":4979.0,"shares_owned_after_display":"4,979","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-10-01","filed_date":"2009-10-05","scope":"insider"},{"id":5690450,"accession":"0001181431-09-007883","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-09-007883","line_url":"/filing/0001181431-09-007883#line-2","is_derivative":false,"issuer_cik":"0001401923","issuer_name":"MAP Pharmaceuticals, Inc.","issuer_ticker":"MAPP","issuer_name_source":null,"issuer_url":"/issuer/0001401923","owner_cik":"0001413823","owner_name":"CHAI CHRISTOPHER Y","owner_display_name":"CHAI CHRISTOPHER Y","owner_url":"/insider/0001413823","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21.0,"shares_display":"21","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":273.0,"total_display":"273.00","total_whole":"273","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-02-09","filed_date":"2009-02-11","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":18,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":18,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":18},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001510487","name":"Principia Biopharma Inc.","url":"/issuer/0001510487","role":"Officer (Chief Financial Officer)","n_filings":3,"first_seen":"2020-02-20","last_seen":"2020-08-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001401923","name":"MAP Pharmaceuticals, Inc.","url":"/issuer/0001401923","role":"Officer (Chief Financial Officer)","n_filings":8,"first_seen":"2009-02-11","last_seen":"2011-09-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001413823","retrieved_at":"2026-08-23T12:32:50+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}